Stanford University
Showing 28,361-28,380 of 37,047 Results
-
Kyoko Sato
Associate Director, Science, Technology and Society
BioKyoko Sato is Associate Director of the Program in Science, Technology, and Society at Stanford University. Her research examines technoscientific governance in Japan and the United States. Her areas of research include: the politics of expertise; nuclear politics; narratives and representation of nuclear technology and radiation protection; and Covid-19 governance. She co-edited (with Soraya Boudia and Bernadette Bensaude Vincent) Living in a Nuclear World: From Fukushima to Hiroshima, a 2022 interdisciplinary post-Fukushima reflection on the development of the global nuclear order. She has conducted fieldwork in various areas affected by nuclear technology (e.g., Fukushima, Hiroshima, Nagasaki; communities surrounding TMI, Hanford site, and other facilities; Church Rock) to examine the dynamics and relationships among global and national nuclear governance, expertise, and democratic citizenship. Her previous work examined interdisciplinary knowledge production in the United States and the politics of genetically modified food in France, Japan, and the United States. She has published in journals such as Science, Technology and Human Values; East Asian Science, Technology and Society; Theory and Society; and 科学技術社会論研究 (Journal of Science and Technology Studies; in Japanese) and book chapters on the Fukushima disaster both in English and in Japanese. She worked as a journalist in Tokyo before pursuing her PhD in sociology from Princeton University.
-
Takahiro Sato
Lead Scientist, SLAC National Accelerator Laboratory
Current Role at StanfordStaff Scientist of Material Science Department, LCLS.
Instrument lead scientist of the XPP instrument.
Principal Investigator, Stanford PULSE Institute -
Ansuman Satpathy, MD, PhD
Associate Professor of Pathology
Current Research and Scholarly InterestsOur lab works at the interface of immunology, cancer biology, and genomics to study cellular and molecular mechanisms of the immune response to cancer. In particular, we are leveraging high-throughput genomic technologies to understand the dynamics of the tumor-specific T cell response to cancer antigens and immunotherapies (checkpoint blockade, CAR-T cells, and others). We are also interested in understanding the impact of immuno-editing on the heterogeneity and clonal evolution of cancer.
-
Neda Sattarnezhad Oskouei, MD, MS
Instructor, Medicine - Immunology & Rheumatology
BioDr. Neda Sattarnezhad Oskouei is a board-certified neurologist and neuroimmunologist specializing in Multiple Sclerosis (MS) and neuroimmunological disorders, including Neuromyelitis Optica (NMO), MOG Antibody Disease (MOGAD), optic neuritis, transverse myelitis, autoimmune encephalitis, neuro-rheumatological conditions, and neuroinfectious diseases. Her research focuses on understanding the role of pathogens in triggering autoimmunity, with a particular emphasis on the role of Epstein-Barr Virus (EBV) in the development of MS.
Dr. Sattarnezhad earned her MD degree with honors from Tabriz University of Medical Sciences. She completed a research fellowship in Multiple Sclerosis at the Brigham MS Center, Harvard Medical School, before pursuing her residency in adult neurology at the University of Illinois at Chicago. She further specialized by completing a clinical fellowship in Multiple Sclerosis and Neuroimmunology at Stanford University as a Sylvia Lawry Fellow of the National MS Society, during which she also earned a master’s degree in Epidemiology and Clinical Research. She subsequently completed a fellowship in immunology and rheumatology at Stanford.
Her research and training have been supported by the National MS Society (NMSS), National Institutes of Health (NIH), and National Institute of Allergy and Infectious Diseases (NIAID). -
Elizabeth Sattely
Associate Professor of Chemical Engineering
BioPlants have an extraordinary capacity to harvest atmospheric CO2 and sunlight for the production of energy-rich biopolymers, clinically used drugs, and other biologically active small molecules. The metabolic pathways that produce these compounds are key to developing sustainable biofuel feedstocks, protecting crops from pathogens, and discovering new natural-product based therapeutics for human disease. These applications motivate us to find new ways to elucidate and engineer plant metabolism. We use a multidisciplinary approach combining chemistry, enzymology, genetics, and metabolomics to tackle problems that include new methods for delignification of lignocellulosic biomass and the engineering of plant antibiotic biosynthesis.
-
Amelia Sattler, MD
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsCurrently working on projects identifying effective use of actual patient encounters in undergraduate medical education. Specifically interested in the role of actual patient encounters in the training of shared decision making. Also interested in medical student empathy and physician wellness.
Also working on many different projects in the realm of quality improvement and population health in the Division of Primary Care and Population Health.
